PMID: 696424Jan 1, 1978Paper

Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin

Acta Medica Scandinavica
H J KornerupV P Petersen

Abstract

The present report describes a case of potassium-wasting nephropathy with the physiological and endocrinological findings that are typical for Bartter's syndrome (BS). However, the renal juxtaglomerular apparatus showed no hyperplasia at two renal biopsies two years apart. The short-term (9 days) effect of indomethacin in combination with spironolactone was a suppression of hyperreninemia and hyperaldosteronism and an increase in vascular sensitivity to angiotensin II associated with potassium and sodium retention. Subsequently, on indomethacin alone, potassium balance was obtained on a lower level with persistent hypokalemia and persistent renal potassium leakage. Hypokalemia persisted during long-term (9 months) treatment with indomethacin despite normalization of the activity of the renin-aldosterone system. The results indicate that indomethacin as long-term treatment may be ineffective in maintaining a normal potassium balance in BS.

References

Sep 18, 1976·Lancet·L NorbyP Ramwell
May 31, 1976·The American Journal of Medicine·M P FichmanR Rude
Oct 1, 1976·Toxicology and Applied Pharmacology·C D Klaassen
Dec 1, 1970·Scandinavian Journal of Clinical and Laboratory Investigation·J GieseO Munck
Nov 1, 1973·The American Journal of Medicine·D W Erkelens, L W Statius van Eps
Dec 1, 1974·The American Journal of Medicine·W Z PotterW E Judson
Jun 1, 1972·The Journal of Clinical Investigation·J D GardnerS Shibolet
Apr 1, 1971·The Journal of Clinical Endocrinology and Metabolism·G GallR Klein
Jan 1, 1966·Scandinavian Journal of Clinical and Laboratory Investigation·J Funder, J O Wieth
Apr 1, 1964·The Journal of Clinical Investigation·N M KAPLAN, J G SILAH
Sep 1, 1951·The American Journal of Medicine·D P EARLEN J CONAN

❮ Previous
Next ❯

Citations

Jan 1, 1982·Acta Medica Scandinavica·R JulkunenT A Miettinen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

The Korean Journal of Internal Medicine
J W ParkY J Kang
The Journal of Clinical Endocrinology and Metabolism
A LechiL A Scuro
American Journal of Ophthalmology
G MarchiniM Zarbin
© 2021 Meta ULC. All rights reserved